ArticleSkin health and disease2026
Expression of interleukins in adult female acne: evaluating the effects of azelaic acid.
Article in Skin health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adult female acne (AFA) is a multifactorial skin condition that affects women aged > 25 years, with inflammation playing a central role in its aetiopathogenesis. However, most research has primarily focused on severe acne vulgaris, while the immunological mechanisms underlying AFA remain poorly understood. Objectives: To analyse interleukin (IL)-6 and IL-8 expression in inflammatory lesions of AFA, before and after treatment with topical azelaic acid (AZA) 15% gel, and compare the findings with healthy skin; and to evaluate the efficacy of AZA based on clinical response and histopathological findings. Methods: Twenty women with mild-to-moderate AFA used AZA 15% gel twice daily for 6 months, with monthly follow-ups. Skin biopsies from lesional and healthy facial areas were collected at baseline and at treatment completion to assess IL-6 and IL-8 by immunohistochemistry and to score inflammation. Clinical evaluation, including Visia Results: There was significant overexpression of IL-6 and IL-8 in acne lesions compared with healthy skin, Conclusions: IL-6 and IL-8 expressions are increased in AFA, contributing to its inflammatory process. Therapies that reduce these proinflammatory cytokines, such as AZA, are beneficial. Our findings are consistent with a potential anti-inflammatory effect of AZA, given the observed decrease in IL-6 and IL-8.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.